Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation

1 Oct 1996

Abstract excerpt

OBJECTIVE: To determine the prevalence of increased fetal nuchal translucency thickness in twin pregnancies and to evaluate screening for trisomy 21 by a combination of translucency thickness and maternal age. DESIGN: Prospective screening study at 10 to 14 weeks of gestation. SETTING: Fetal Medicine Centre. POPULATION: 22,518 self-selected pregnant women at 10 to 14 weeks of gestation, including 21,477 singleton...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8863698
DOI: 10.1111/j.1471-0528.1996.tb09550.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestationPMID 8863698Read ↗

Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestationSemantic proximity Read ↗

Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thicknessSemantic proximity Read ↗

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.Semantic proximity Read ↗

Relation between increased fetal nuchal translucency thickness and chromosomal defects.Semantic proximity Read ↗

Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestationSemantic proximity Read ↗

Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancySemantic proximity Read ↗

Detection of sex chromosome abnormalities by nuchal translucency screening at 10–14 weeksSemantic proximity Read ↗

Prospective validation of first‐trimester combined screening for trisomy 21Semantic proximity Read ↗

Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markersSemantic proximity Read ↗

Clinical performance of non‐invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta‐analysisSemantic proximity Read ↗

Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non‐invasive prenatal testing?Semantic proximity Read ↗

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐ASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.